Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
By inhibiting NNMT, the compound preserves these critical cofactors, restoring sirtuin activity and normal energy expenditure in adipocytes
What can you expect in your appointment
We value your feedback on our articles, if you have a well-researched paper you would like to share with us please contact us
Use In Specific Populations Pregnancy Risk Summary EGRIFTA WR is contraindicated in pregnant women because modifying visceral adipose tissue offers no benefit in pregnant women and could result in fetal harm [see Clinical Considerations and CONTRAINDICATIONS ]
10.1146/annurev.bi.53.070184.003441 34 ForslundC.AspenbergP
US$ 21.94
US$ 23.69
US$ 22.54
